4GUV
TetX derivatized with Xenon
Summary for 4GUV
| Entry DOI | 10.2210/pdb4guv/pdb |
| Related | 2XDO 2XYO 2Y6Q 2Y6R |
| Descriptor | TetX2 protein, FLAVIN-ADENINE DINUCLEOTIDE, SULFATE ION, ... (5 entities in total) |
| Functional Keywords | rossmann fold, monooxygenase, xenon, oxidoreductase |
| Biological source | Bacteroides thetaiotaomicron |
| Total number of polymer chains | 4 |
| Total formula weight | 184062.82 |
| Authors | Volkers, G.,Palm, G.J.,Panjikar, S.,Hinrichs, W. (deposition date: 2012-08-29, release date: 2013-04-10, Last modification date: 2023-09-13) |
| Primary citation | Volkers, G.,Damas, J.M.,Palm, G.J.,Panjikar, S.,Soares, C.M.,Hinrichs, W. Putative dioxygen-binding sites and recognition of tigecycline and minocycline in the tetracycline-degrading monooxygenase TetX. Acta Crystallogr.,Sect.D, 69:1758-1767, 2013 Cited by PubMed Abstract: Expression of the aromatic hydroxylase TetX under aerobic conditions confers bacterial resistance against tetracycline antibiotics. Hydroxylation inactivates and degrades tetracyclines, preventing inhibition of the prokaryotic ribosome. X-ray crystal structure analyses of TetX in complex with the second-generation and third-generation tetracyclines minocycline and tigecycline at 2.18 and 2.30 Å resolution, respectively, explain why both clinically potent antibiotics are suitable substrates. Both tetracyclines bind in a large tunnel-shaped active site in close contact to the cofactor FAD, pre-oriented for regioselective hydroxylation to 11a-hydroxytetracyclines. The characteristic bulky 9-tert-butylglycylamido substituent of tigecycline is solvent-exposed and does not interfere with TetX binding. In the TetX-minocycline complex a second binding site for a minocycline dimer is observed close to the active-site entrance. The pocket is formed by the crystal packing arrangement on the surface of two neighbouring TetX monomers. Crystal structure analysis at 2.73 Å resolution of xenon-pressurized TetX identified two adjacent Xe-binding sites. These putative dioxygen-binding cavities are located in the substrate-binding domain next to the active site. Molecular-dynamics simulations were performed in order to characterize dioxygen-diffusion pathways to FADH2 at the active site. PubMed: 23999299DOI: 10.1107/S0907444913013802 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.73 Å) |
Structure validation
Download full validation report






